WebFeb 4, 2024 · Cytophage Technologies Inc. entered into a letter of intent to acquire Cuspis Capital II Ltd. (TSXV:CCII.P) in a reverse merger transaction on February 14, … WebFeb 4, 2024 · Cuspis Capital II Ltd. and Cytophage Technologies Inc. Announce Termination of Letter of Intent. Toronto, Ontario –TheNewswire - May 6, 2024 – Cuspis …
Stock Market Daily Herald
WebFor its year ended December 31, 2024, Cytophage had total assets of $5.995 million and total liabilities of $392,099, for net tangible assets of $5.6 million. Cytophage had nil revenues in its fiscal 2024, and net income (loss) of … WebCytophage Technologies Inc. Biotechnology Research Winnipeg, Manitoba 443 followers Award-winning biotechnology company specializing in bacteriophage therapy development, based in Winnipeg, Manitoba. cht newborn blood spot
Cytophage Technologies Inc. - Public Company Information
WebFeb 4, 2024 · Cytophage Technologies Inc. entered into a letter of intent to acquire Cuspis Capital II Ltd. in a reverse merger transaction on February 14, 2024. Pursuant to the transaction,... Advanced search WebApr 6, 2024 · Cytophage Technologies Inc. is a Canadian private corporation that has an innovative template technology that uses synthetic biology to create tailor-made bacteriophage products that can bind to and kill bacterial cells. This technology has commercial applications in human health, animal health and food safety. ... WebCytophage in the news News Release Winnipeg Biotech Company Tests New Ways of Fighting Common Swine Diseases Manitoba biotech company Cytophage … Cytophage is developing bacteriophages that will reduce and ultimately replace … Cytophage Technologies Inc. Selected to Join the Wells Fargo Innovation … Antibiotics are valuable tools for reducing human and animal disease and … Attacking bacteria with bacteriophage presents an alternative approach to … Cytophage offers a solution with tailor-made synthetic bacteriophages that combat … desert fawn paint color sherwin williams